Post‐transplant lymphoproliferative disorders, Epstein‐Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice

Citations Over TimeTop 1% of 2019 papers

Abstract

These updated guidelines from the American Society of Transplantation Infectious Diseases Community of Practice review the diagnosis, management, and prevention of post-transplant lymphoproliferative disorders (PTLD) and other Epstein-Barr virus (EBV) syndromes after solid organ transplantation. PTLD are a heterogeneous spectrum of predominantly B-cell disorders, often extra-nodal, with complex distinct pathogeneses and variable clinical presentations determined by pathologic subtype. Recent epidemiologic studies report a decrease in early EBV-positive (+) PTLD and an increase in late EBV-negative (-) PTLD. Pre-transplant EBV-seronegativity and primary EBV infection, often from donor-transmitted infection, are an important risk factors for EBV syndromes and early EBV + PTLD. Low-quality evidence supports preemptive prevention strategies for early EBV + PTLD in EBV-seronegative recipients that involve EBV DNA measurement in peripheral blood using assays requiring further result harmonization, combined with interventions to lower viral load. Reduction in immunosuppression (RIS) is the best validated intervention. WHO pathology classification of a tissue biopsy remains the gold standard for PTLD diagnosis; optimal staging procedures are uncertain. Treatment of CD20+ PTLD with the response-dependent sequential use of RIS, rituximab, and cytotoxic chemotherapy is recommended. Evidence gaps requiring future research and alternate treatment strategies including immunotherapy are highlighted.

Related Papers

• → Management of posttransplant lymphoproliferative disorders following solid organ transplant: an update(2011)23 cited
• → Signet Ring Cell Primary Cutaneous CD30+ Lymphoproliferative Disorder Presenting as a Monomorphic T-Cell Posttransplant Lymphoproliferative Disease(2012)1 cited
• → Special issue : Lymphoproliferative diseases.Lymphoproliferative diseases : An advance on diagnosis and treatments.Diagnosis.Procedure of diagnosis of lymphoproliferative disease.(1994)
• → Management of Skin Cancers in Solid Organ Transplant Recipients(2009)
• → Prevention and Treatment of Epstein—Barr Virus Associated Lymphoproliferative Disorders in Recipients of Bone Marrow and Solid Organ Transplants(2003)